Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

King Global Ventures Inc (KING.CN)

King Global Ventures Inc (KING.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Canadian Securities Exchange Reports July 2024 Performance Figures Newsfile - Wed Aug 14, 1:50PM CDT

Toronto, Ontario--(Newsfile Corp. - August 14, 2024) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for July 2024.July 2024 Operating StatisticsTrading volume...

AMQ.CN : 0.3950 (+6.76%)
ASE.CN : 1.2000 (-2.44%)
BPAI.CN : 0.0250 (unch)
GSTR.CN : 0.3000 (+20.00%)
KING.CN : 0.3800 (-9.52%)
Canadian Securities Exchange Welcomes Listing of King Global Ventures Inc Newsfile - Tue Jul 16, 11:22AM CDT

Toronto, Ontario--(Newsfile Corp. - July 16, 2024) - The Canadian Securities Exchange ("CSE" or "the Exchange") today welcomed the listing of King Global Ventures Inc. ("King Global" or the "Company")....

KING.CN : 0.3800 (-9.52%)

Barchart Exclusives

Buy This Pharma Stock to Bet on the Next Blockbuster Weight-Loss Drug Barchart - 7 minutes ago
A shocking study in The Lancet showed that nearly three-quarters of U.S. adults are overweight or obese. Chances are that by 2050, there will be 260 million overweight Americans. We already have GLP-1 drugs, and amylin-based drugs are next. Novo Nordisk's compound, Cagrilintide, will be combined with semaglutide in its next blockbuster drug, CagriSema. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot